Capital $25M for Rapid Micro Biosystems

Rapid Micro Biosystems 67922_RapidMicroLogoPRraised 25 million dollars in a Series C round. The company provides innovative products for faster detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. As of the investors that participated at the funding round, they include Hepalink USA, Richard K. Mellon and Sons, Kleiner Perkins Caufield & Byers,Longitude Capital, Quaker Partners, TPG Biotech and TVM Capital.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More